Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

Also called NCT03102502

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 110 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03102502
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03102502. Randomized; single masking; primary purpose treatment. Start 2017-03-10 (actual); primary completion 2018-10-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status
Acronym
EECPVHS
Condition
Coronary Heart Disease
Intervention (Device)
EECP
Intervention (Drug)
Medical therapy
Lead sponsor
Sun Yat-sen University (class: other)

Record details

Record id
cardio:ct-nct03102502
Content hash
351a9f197aaeefc49d57e560707f02523d0edaa0246697acc174c177f1e687e2